K182265 is an FDA 510(k) clearance for the CodMan Certas Plus Programmable Valve. Classified as Shunt, Central Nervous System And Components (product code JXG), Class II - Special Controls.
Submitted by Integra Lifesciences Corp. (Mansfield, US). The FDA issued a Cleared decision on November 20, 2018 after a review of 91 days - within the typical 510(k) review window.
This device falls under the Neurology FDA review panel, regulated under 21 CFR 882.5550 - the FDA neurology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.
Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Neurology review framework, consistent with the majority of Class II 510(k) submissions.